StevenJoelRichardsMD

PubMed

• 65 citations
  Discovery of XL413, a potent and selective CDC7 inhibitor.
  Elena S. Koltun, Amy Lew Tsuhako, Brown S David, Naing Aay, Arlyn Arcalas, Vicky Chan, Hongwang Du, Stefan Engst, Kim Ferguson, Maurizio Franzini, Adam A. Galan, Charl...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Jun 1
• 13 citations
  Discovery and characterization of an inhibitor of glucosylceramide synthase.
  Richards Steven J, Christopher J. Larson, Elena S. Koltun, Art Hanel, Vicky Chan, Jason August Nachtigall, Amanda Harrison, Naing Aay, Hongwang Du, Arlyn Arcalas, Adam...> ;Journal of Medicinal Chemistry. 2012 Apr 19
• 10 citations
  Discovery of a new class of glucosylceramide synthase inhibitors.
  Elena S. Koltun, Richards Steven J, Vicky Chan, Jason August Nachtigall, Hongwang Du, Kevin Noson, Adam A. Galan, Naing Aay, Art Hanel, Amanda Harrison, Jeff Zhang, Kw...> ;Bioorganic & Medicinal Chemistry Letters. 2011 Nov 15
• 17 citations
  Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome
  Richards Steven J, Bryan K. Sorensen, Jae Hwan-Soo, M. Winn, Yixian Chen, Jiahong Wang, Steven Fung, Katina Monzon, Ernst U. Frevert, Peer B. Jacobson, Hing L. Sham, J...> ;Bioorganic & Medicinal Chemistry Letters. 2006 Dec 15
• 5 citations
  Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists.
  Richards Steven J, Thomas W. von Geldern, Peer B. Jacobson, Denise Wilcox, Phong Nguyen, Lars Öhman, Marie K. Österlund, Birgitta Gelius, Marlena Grynfarb, Annika Goos...> ;Bioorganic & Medicinal Chemistry Letters. 2006 Dec 1
• 26 citations
  Discovery of 2-[4-{{2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic Acid (ABT-279): A Very Potent, Selectiv...
  David Madar, Hana Kopecka, Daisy Pireh, Hong Yong, Zhonghua Pei, Xiaofeng Li, Paul E. Wiedeman, Stevan W. Djuric, Thomas W. von Geldern, Michael G. Fickes, Lakshmi Bha...> ;Journal of Medicinal Chemistry. 2006 Sep 23
• N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.
  Boot JR, Boulet SL, Clark BP, Cases-Thomas MJ, Delhaye L, Diker K, Fairhurst J, Findlay J, Gallagher PT, Gilmore J, Harris JR, Masters JJ, Mitchell SN, Naik M, Simmond...> ;Bioorg. Med. Chem. Lett.. 2006-05-15
• Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
  Boot JR, Brace G, Delatour CL, Dezutter N, Fairhurst J, Findlay J, Gallagher PT, Hoes I, Mahadevan S, Mitchell SN, Rathmell RE, Richards SJ, Simmonds RG, Wallace L, Wh...> ;Bioorg. Med. Chem. Lett.. 2004-11-01
• Potential drug targets and progress towards pharmacologic inhibition of hepatic glucose production.
  Kurukulasuriya R, Link JT, Madar DJ, Pei Z, Richards SJ, Rohde JJ, Souers AJ, Szczepankiewicz BG> ;Curr. Med. Chem.. 2003-01-01
• Prospects for pharmacologic inhibition of hepatic glucose production.
  Kurukulasuriya R, Link JT, Madar DJ, Pei Z, Rohde JJ, Richards SJ, Souers AJ, Szczepankiewicz BG> ;Curr. Med. Chem.. 2003-01-01
• Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
  Fenton, J. A., Pratt, G., Rawstron, A. C., Sibley, K., Rothwell, D., Yates, Z., Dring, A., Richards, S. J., Ashcroft, A. J., Davies, F. E., Owen, R. G., Child, J. A., ...> ;Oncogene. 2003 Feb 20
• Join now to see all